Clinical trial
Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin -The CLEAR PLATELETS-2 Study
NCT00370045 is registered in ClinicalTrials.gov with LifeBridge Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin -The CLEAR PLATELETS-2 Study
- Lead sponsor
- LifeBridge Health
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- March 31, 2006
- Completion date
- Not reported
- Enrollment
- 200
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.